Epidemiological Characterizations of Class 1 Integrons from Multidrug-Resistant Acinetobacter Isolates in Daejeon, Korea
Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type a...
Saved in:
Published in | Annals of laboratory medicine Vol. 34; no. 4; pp. 293 - 299 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society for Laboratory Medicine
01.07.2014
대한진단검사의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2234-3806 2234-3814 2234-3814 |
DOI | 10.3343/alm.2014.34.4.293 |
Cover
Abstract | Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods.
Fifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing.
Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI MP-1 -bla OXA-2), 3.0-kb type C (bla VIM-2-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla OXA-2 -orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria.
Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates. |
---|---|
AbstractList | Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods.
Fifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing.
Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI MP-1 -bla OXA-2), 3.0-kb type C (bla VIM-2-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla OXA-2 -orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria.
Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates. Background: Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent- resistance genes via class 1 integrons. In this study, integrons were characterized to inves- tigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addi- tion, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods. Methods: Fifty-six MDR Acinetobacter spp.- A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory con- centrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palin- dromic sequence (REP)-PCR were performed for epidemiological typing. Results: Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A ( aacA4 - catB8 - aadA1 ), 3.0-kb type B ( aacA4 - blaI MP-1 - bla OXA-2 ), 3.0-kb type C ( bla VIM-2 - aacA7 - aadA1 ), and 1.8-kb type D ( aac3 - 1 - bla OXA-2 - orfD ). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. bauman- nii isolates, regardless of clone and separation time of the bacteria. Conclusions: Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non- baumannii Acinetobacter isolates. KCI Citation Count: 8 Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods.BACKGROUNDMultidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to investigate the antimicrobial resistance mechanisms of MDR Acinetobacter isolates. In addition, the relationship between the integron type and integron-harboring bacterial species was analyzed by using epidemiological typing methods.Fifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing.METHODSFifty-six MDR Acinetobacter spp.-A. baumannii (N=30), A. bereziniae (N=4), A. nosocomialis (N=5), and A. pittii (N=17)-were isolated. The minimum inhibitory concentrations (MICs) were determined on the basis of the results of the Epsilometer test (Etest). PCR and DNA sequencing was performed to characterize the gene cassette arrays of class 1 integrons. Multilocus sequence typing (MLST) and repetitive extragenic palindromic sequence (REP)-PCR were performed for epidemiological typing.Class 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI MP-1 -bla OXA-2), 3.0-kb type C (bla VIM-2-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla OXA-2 -orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria.RESULTSClass 1 integrons were detected in 50 (89.3%) of the 56 isolates, but no class 2 or 3 integron was found within the cohorts. The class 1 integrons were classified into 4 types: 2.3-kb type A (aacA4-catB8-aadA1), 3.0-kb type B (aacA4-blaI MP-1 -bla OXA-2), 3.0-kb type C (bla VIM-2-aacA7-aadA1), and 1.8-kb type D (aac3-1-bla OXA-2 -orfD). Type A was most prevalent and was detected only in A. baumannii isolates, except for one A. bereziniae isolate; however, type B was amplified in all Acinetobacter isolates except for A. baumannii isolates, regardless of clone and separation time of the bacteria.Although class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates.CONCLUSIONSAlthough class 1 integron can be transferred horizontally between unrelated isolates belonging to different species, certain types of class 1 integrons tend to transfer horizontally and vertically among A. baumannii or non-baumannii Acinetobacter isolates. |
Author | Koo, Sun Hoe Kwon, Kye Chul Sung, Ji Youn Kim, Semi |
AuthorAffiliation | 1 Department of Biomedical Laboratory Science, Far East University, Eumseong, Korea 2 Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea |
AuthorAffiliation_xml | – name: 1 Department of Biomedical Laboratory Science, Far East University, Eumseong, Korea – name: 2 Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea |
Author_xml | – sequence: 1 givenname: Ji Youn surname: Sung fullname: Sung, Ji Youn organization: Department of Biomedical Laboratory Science, Far East University, Eumseong, Korea – sequence: 2 givenname: Sun Hoe surname: Koo fullname: Koo, Sun Hoe organization: Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea – sequence: 3 givenname: Semi surname: Kim fullname: Kim, Semi organization: Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea – sequence: 4 givenname: Kye Chul surname: Kwon fullname: Kwon, Kye Chul organization: Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24982834$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001886898$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1kktv1DAUhSNUREvpD2CDvGRBgl_JxBuk0bTAiCKkqqytG-dm6taxB9tBwK8nM0PLQ8Kba9nfOWdxz9PiyAePRfGc0UoIKV6DGytOmayErGTFlXhUnHAuZClaJo8e7rQ5Ls5SuqXzaSjjij4pjrlULW-FPCm-XWxtj6MNLmysAUdWNxDBZIz2B2QbfCJhICsHKRFG1j7jJu4ehxhG8nFy2fZx2pRXmGzK4DNZGusxh27vQdYpOMiYiPXkHPAWg39FPoSI8Kx4PIBLePZrnhaf315cr96Xl5_erVfLy9JIwXOJdW1oJ1XdtbzvFSgQ2DBKoR2gkUph1zesGbpuIZAhXyhssAcjVE1bwQ0Vp8XLg6-Pg74zVgew-7kJ-i7q5dX1WjPJqWxm9M0B3U7diL1BnyM4vY12hPh9L_z7x9ub2earlnTBWNv8ztrG8GXClPVok0HnwGOYkma15FypRatm9MWfWQ8h95uZgcUBMDGkFHHQxub9RuZo6zSjelcDPddA72qghdRSzzWYlewf5b35_zU_AV73t_o |
CitedBy_id | crossref_primary_10_3390_ijms22158080 crossref_primary_10_1099_jmm_0_000315 crossref_primary_10_1007_s11356_017_0945_7 crossref_primary_10_1097_MRM_0000000000000270 crossref_primary_10_5812_jjm_13100 crossref_primary_10_1080_1120009X_2015_1133014 crossref_primary_10_3389_fmicb_2016_00049 crossref_primary_10_1016_j_ijfoodmicro_2019_01_015 crossref_primary_10_1089_mdr_2019_0210 crossref_primary_10_1089_mdr_2020_0442 crossref_primary_10_1186_s12866_023_03049_8 crossref_primary_10_1016_j_joad_2016_08_004 crossref_primary_10_31631_2073_3046_2018_17_3_27_31 crossref_primary_10_1186_s12879_016_1526_y |
Cites_doi | 10.1371/journal.pone.0010034 10.3349/ymj.2013.54.1.177 10.1016/j.mimet.2005.02.007 10.1046/j.1469-0691.2000.00181.x 10.1097/01.qco.0000171920.44809.f0 10.1099/jmm.0.45716-0 10.1128/JCM.00014-08 10.3343/kjlm.2011.31.4.265 10.1128/JCM.00967-09 10.1186/1476-0711-8-21 10.1128/JCM.01759-12 10.1586/14787210.6.3.309 10.1099/mic.0.026054-0 10.1086/529198 10.1016/j.ijantimicag.2011.08.006 10.1128/JCM.43.9.4382-4390.2005 10.1093/jac/dkn179 10.1128/JCM.02373-10 10.1128/AAC.45.9.2658-2661.2001 10.1128/AAC.01728-10 10.1016/j.ijantimicag.2012.05.017 10.3389/fmicb.2012.00148 10.1016/j.diagmicrobio.2009.02.010 10.1128/AAC.46.11.3665-3668.2002 10.1093/clinids/22.6.1026 10.1038/nrmicro1462 10.1146/annurev-genet-102209-163504 10.1016/j.ijantimicag.2009.11.020 10.1128/JCM.43.7.3074-3082.2005 |
ContentType | Journal Article |
Copyright | The Korean Society for Laboratory Medicine. 2014 |
Copyright_xml | – notice: The Korean Society for Laboratory Medicine. 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.3343/alm.2014.34.4.293 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2234-3814 |
EndPage | 299 |
ExternalDocumentID | oai_kci_go_kr_ARTI_142046 PMC4071186 24982834 10_3343_alm_2014_34_4_293 |
Genre | Journal Article |
GeographicLocations | Republic of Korea |
GeographicLocations_xml | – name: Republic of Korea |
GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL AAYXX ACYCR ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION C~G DIK DYU EF. GX1 HYE KQ8 M48 PGMZT RPM CGR CUY CVF ECGQY ECM EIF EMOBN NPM 7X8 5PM M~E OK1 OZF |
ID | FETCH-LOGICAL-c432t-e55c0b495b82dd9a9a3e6100a8fa6499ebd616fbb73e1e279e6edac3950832c03 |
IEDL.DBID | M48 |
ISSN | 2234-3806 2234-3814 |
IngestDate | Tue Nov 21 21:41:27 EST 2023 Thu Aug 21 18:02:31 EDT 2025 Thu Jul 10 16:30:42 EDT 2025 Thu Apr 03 07:05:57 EDT 2025 Tue Jul 01 03:11:32 EDT 2025 Thu Apr 24 23:01:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Sequence types MDR Acinetobacter spp MLST Integron |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c432t-e55c0b495b82dd9a9a3e6100a8fa6499ebd616fbb73e1e279e6edac3950832c03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000327.2014.34.4.011 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3343/alm.2014.34.4.293 |
PMID | 24982834 |
PQID | 1542299789 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_142046 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4071186 proquest_miscellaneous_1542299789 pubmed_primary_24982834 crossref_citationtrail_10_3343_alm_2014_34_4_293 crossref_primary_10_3343_alm_2014_34_4_293 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-07-01 |
PublicationDateYYYYMMDD | 2014-07-01 |
PublicationDate_xml | – month: 07 year: 2014 text: 2014-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Annals of laboratory medicine |
PublicationTitleAlternate | Ann Lab Med |
PublicationYear | 2014 |
Publisher | The Korean Society for Laboratory Medicine 대한진단검사의학회 |
Publisher_xml | – name: The Korean Society for Laboratory Medicine – name: 대한진단검사의학회 |
References | Srinivasan (10.3343/alm.2014.34.4.293_ref16) 2009; 8 Park (10.3343/alm.2014.34.4.293_ref28) 2012; 39 Cambray (10.3343/alm.2014.34.4.293_ref10) 2010; 44 Da Silva (10.3343/alm.2014.34.4.293_ref11) 2002; 215 Clinical and Laboratory Standards Institute (10.3343/alm.2014.34.4.293_ref18) 2010 White (10.3343/alm.2014.34.4.293_ref20) 2001; 45 van den Broek (10.3343/alm.2014.34.4.293_ref7) 2009; 47 Golanbar (10.3343/alm.2014.34.4.293_ref25) 2011; 49 Roca (10.3343/alm.2014.34.4.293_ref31) 2012; 3 Cisneros (10.3343/alm.2014.34.4.293_ref3) 1996; 22 Bartual (10.3343/alm.2014.34.4.293_ref22) 2005; 43 Higgins (10.3343/alm.2014.34.4.293_ref29) 2012; 50 Gundi (10.3343/alm.2014.34.4.293_ref17) 2009; 155 Machado (10.3343/alm.2014.34.4.293_ref9) 2008; 62 Gombac (10.3343/alm.2014.34.4.293_ref12) 2002; 46 Diancourt (10.3343/alm.2014.34.4.293_ref21) 2010; 5 Wu (10.3343/alm.2014.34.4.293_ref24) 2012; 40 Nemec (10.3343/alm.2014.34.4.293_ref13) 2004; 53 Gootz (10.3343/alm.2014.34.4.293_ref8) 2008; 6 Turton (10.3343/alm.2014.34.4.293_ref26) 2005; 43 Maragakis (10.3343/alm.2014.34.4.293_ref1) 2008; 46 Mazel (10.3343/alm.2014.34.4.293_ref14) 2006; 4 Lin (10.3343/alm.2014.34.4.293_ref27) 2010; 35 Dillon (10.3343/alm.2014.34.4.293_ref19) 2005; 62 Ko (10.3343/alm.2014.34.4.293_ref6) 2008; 46 Esterly (10.3343/alm.2014.34.4.293_ref5) 2011; 55 Navon-Venezia (10.3343/alm.2014.34.4.293_ref2) 2005; 18 Park (10.3343/alm.2014.34.4.293_ref30) 2013; 54 Cho (10.3343/alm.2014.34.4.293_ref15) 2009; 64 Sung (10.3343/alm.2014.34.4.293_ref4) 2011; 31 Bou (10.3343/alm.2014.34.4.293_ref23) 2000; 6 16145081 - J Clin Microbiol. 2005 Sep;43(9):4382-90 22895032 - J Clin Microbiol. 2012 Nov;50(11):3493-500 20707672 - Annu Rev Genet. 2010;44:141-66 20106635 - Int J Antimicrob Agents. 2010 May;35(5):439-43 12393197 - FEMS Microbiol Lett. 2002 Sep 24;215(1):33-9 21825287 - Antimicrob Agents Chemother. 2011 Oct;55(10):4844-9 15985826 - Curr Opin Infect Dis. 2005 Aug;18(4):306-13 16009279 - J Microbiol Methods. 2005 Aug;62(2):221-32 19389786 - Microbiology. 2009 Jul;155(Pt 7):2333-41 21996405 - Int J Antimicrob Agents. 2012 Jan;39(1):81-5 20383326 - PLoS One. 2010;5(4):e10034 11284921 - Clin Microbiol Infect. 2000 Dec;6(12):635-43 19361944 - Diagn Microbiol Infect Dis. 2009 Jun;64(2):185-90 22016680 - Korean J Lab Med. 2011 Oct;31(4):265-70 15585503 - J Med Microbiol. 2004 Dec;53(Pt 12):1233-40 12384388 - Antimicrob Agents Chemother. 2002 Nov;46(11):3665-8 18385442 - J Clin Microbiol. 2008 Jun;46(6):2052-9 18588496 - Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25 22817917 - Int J Antimicrob Agents. 2012 Sep;40(3):264-7 16000417 - J Clin Microbiol. 2005 Jul;43(7):3074-82 8783704 - Clin Infect Dis. 1996 Jun;22(6):1026-32 23225816 - Yonsei Med J. 2013 Jan 1;54(1):177-82 19794057 - J Clin Microbiol. 2009 Nov;47(11):3593-9 19531268 - Ann Clin Microbiol Antimicrob. 2009;8:21 16845431 - Nat Rev Microbiol. 2006 Aug;4(8):608-20 11502548 - Antimicrob Agents Chemother. 2001 Sep;45(9):2658-61 22536199 - Front Microbiol. 2012 Apr 23;3:148 18456652 - J Antimicrob Chemother. 2008 Aug;62(2):296-302 21450955 - J Clin Microbiol. 2011 Jun;49(6):2121-31 18444865 - Clin Infect Dis. 2008 Apr 15;46(8):1254-63 |
References_xml | – volume: 5 start-page: e10034 year: 2010 ident: 10.3343/alm.2014.34.4.293_ref21 publication-title: PLoS One doi: 10.1371/journal.pone.0010034 – volume: 54 start-page: 177 year: 2013 ident: 10.3343/alm.2014.34.4.293_ref30 publication-title: Yonsei Med J doi: 10.3349/ymj.2013.54.1.177 – volume: 62 start-page: 221 year: 2005 ident: 10.3343/alm.2014.34.4.293_ref19 publication-title: J Microbiol Methods doi: 10.1016/j.mimet.2005.02.007 – volume: 6 start-page: 635 year: 2000 ident: 10.3343/alm.2014.34.4.293_ref23 publication-title: Clin Microbiol Infect doi: 10.1046/j.1469-0691.2000.00181.x – volume: 18 start-page: 306 year: 2005 ident: 10.3343/alm.2014.34.4.293_ref2 publication-title: Curr Opin Infect Dis doi: 10.1097/01.qco.0000171920.44809.f0 – volume: 53 start-page: 1233 year: 2004 ident: 10.3343/alm.2014.34.4.293_ref13 publication-title: J Med Microbiol doi: 10.1099/jmm.0.45716-0 – volume: 46 start-page: 2052 year: 2008 ident: 10.3343/alm.2014.34.4.293_ref6 publication-title: J Clin Microbiol doi: 10.1128/JCM.00014-08 – volume: 31 start-page: 265 year: 2011 ident: 10.3343/alm.2014.34.4.293_ref4 publication-title: Korean J Lab Med doi: 10.3343/kjlm.2011.31.4.265 – volume: 47 start-page: 3593 year: 2009 ident: 10.3343/alm.2014.34.4.293_ref7 publication-title: J Clin Microbiol doi: 10.1128/JCM.00967-09 – volume: 8 start-page: 21 year: 2009 ident: 10.3343/alm.2014.34.4.293_ref16 publication-title: Ann Clin Microbiol Antimicrob doi: 10.1186/1476-0711-8-21 – volume: 50 start-page: 3493 year: 2012 ident: 10.3343/alm.2014.34.4.293_ref29 publication-title: J Clin Microbiol doi: 10.1128/JCM.01759-12 – volume: 6 start-page: 309 year: 2008 ident: 10.3343/alm.2014.34.4.293_ref8 publication-title: Expert Rev Anti Infect Ther doi: 10.1586/14787210.6.3.309 – volume: 155 start-page: 2333 year: 2009 ident: 10.3343/alm.2014.34.4.293_ref17 publication-title: Microbiology doi: 10.1099/mic.0.026054-0 – volume: 46 start-page: 1254 year: 2008 ident: 10.3343/alm.2014.34.4.293_ref1 publication-title: Clin Infect Dis doi: 10.1086/529198 – volume: 39 start-page: 81 year: 2012 ident: 10.3343/alm.2014.34.4.293_ref28 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2011.08.006 – volume: 43 start-page: 4382 year: 2005 ident: 10.3343/alm.2014.34.4.293_ref22 publication-title: J Clin Microbiol doi: 10.1128/JCM.43.9.4382-4390.2005 – volume: 62 start-page: 296 year: 2008 ident: 10.3343/alm.2014.34.4.293_ref9 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkn179 – volume: 49 start-page: 2121 year: 2011 ident: 10.3343/alm.2014.34.4.293_ref25 publication-title: J Clin Microbiol doi: 10.1128/JCM.02373-10 – volume: 45 start-page: 2658 year: 2001 ident: 10.3343/alm.2014.34.4.293_ref20 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.45.9.2658-2661.2001 – volume: 55 start-page: 4844 year: 2011 ident: 10.3343/alm.2014.34.4.293_ref5 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.01728-10 – volume: 40 start-page: 264 year: 2012 ident: 10.3343/alm.2014.34.4.293_ref24 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2012.05.017 – volume: 3 start-page: 148 year: 2012 ident: 10.3343/alm.2014.34.4.293_ref31 publication-title: Front Microbiol doi: 10.3389/fmicb.2012.00148 – volume: 64 start-page: 185 year: 2009 ident: 10.3343/alm.2014.34.4.293_ref15 publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2009.02.010 – volume-title: Performance standards for antimicrobial susceptibility testing. Twentieth Informational supplement, M100-S20 year: 2010 ident: 10.3343/alm.2014.34.4.293_ref18 – volume: 46 start-page: 3665 year: 2002 ident: 10.3343/alm.2014.34.4.293_ref12 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.46.11.3665-3668.2002 – volume: 22 start-page: 1026 year: 1996 ident: 10.3343/alm.2014.34.4.293_ref3 publication-title: Clin Infect Dis doi: 10.1093/clinids/22.6.1026 – volume: 4 start-page: 608 year: 2006 ident: 10.3343/alm.2014.34.4.293_ref14 publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro1462 – volume: 44 start-page: 141 year: 2010 ident: 10.3343/alm.2014.34.4.293_ref10 publication-title: Annu Rev Genet doi: 10.1146/annurev-genet-102209-163504 – volume: 215 start-page: 33 year: 2002 ident: 10.3343/alm.2014.34.4.293_ref11 publication-title: FEMS Microbiol Lett – volume: 35 start-page: 439 year: 2010 ident: 10.3343/alm.2014.34.4.293_ref27 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2009.11.020 – volume: 43 start-page: 3074 year: 2005 ident: 10.3343/alm.2014.34.4.293_ref26 publication-title: J Clin Microbiol doi: 10.1128/JCM.43.7.3074-3082.2005 – reference: 20106635 - Int J Antimicrob Agents. 2010 May;35(5):439-43 – reference: 18456652 - J Antimicrob Chemother. 2008 Aug;62(2):296-302 – reference: 16845431 - Nat Rev Microbiol. 2006 Aug;4(8):608-20 – reference: 23225816 - Yonsei Med J. 2013 Jan 1;54(1):177-82 – reference: 19531268 - Ann Clin Microbiol Antimicrob. 2009;8:21 – reference: 21996405 - Int J Antimicrob Agents. 2012 Jan;39(1):81-5 – reference: 20707672 - Annu Rev Genet. 2010;44:141-66 – reference: 11284921 - Clin Microbiol Infect. 2000 Dec;6(12):635-43 – reference: 8783704 - Clin Infect Dis. 1996 Jun;22(6):1026-32 – reference: 22817917 - Int J Antimicrob Agents. 2012 Sep;40(3):264-7 – reference: 15585503 - J Med Microbiol. 2004 Dec;53(Pt 12):1233-40 – reference: 22536199 - Front Microbiol. 2012 Apr 23;3:148 – reference: 19361944 - Diagn Microbiol Infect Dis. 2009 Jun;64(2):185-90 – reference: 22895032 - J Clin Microbiol. 2012 Nov;50(11):3493-500 – reference: 12384388 - Antimicrob Agents Chemother. 2002 Nov;46(11):3665-8 – reference: 12393197 - FEMS Microbiol Lett. 2002 Sep 24;215(1):33-9 – reference: 21825287 - Antimicrob Agents Chemother. 2011 Oct;55(10):4844-9 – reference: 20383326 - PLoS One. 2010;5(4):e10034 – reference: 18588496 - Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25 – reference: 11502548 - Antimicrob Agents Chemother. 2001 Sep;45(9):2658-61 – reference: 15985826 - Curr Opin Infect Dis. 2005 Aug;18(4):306-13 – reference: 19794057 - J Clin Microbiol. 2009 Nov;47(11):3593-9 – reference: 16000417 - J Clin Microbiol. 2005 Jul;43(7):3074-82 – reference: 18385442 - J Clin Microbiol. 2008 Jun;46(6):2052-9 – reference: 18444865 - Clin Infect Dis. 2008 Apr 15;46(8):1254-63 – reference: 16145081 - J Clin Microbiol. 2005 Sep;43(9):4382-90 – reference: 21450955 - J Clin Microbiol. 2011 Jun;49(6):2121-31 – reference: 22016680 - Korean J Lab Med. 2011 Oct;31(4):265-70 – reference: 19389786 - Microbiology. 2009 Jul;155(Pt 7):2333-41 – reference: 16009279 - J Microbiol Methods. 2005 Aug;62(2):221-32 |
SSID | ssj0000601290 |
Score | 2.0555556 |
Snippet | Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent-resistance genes via class 1 integrons. In this study, integrons were characterized to... Background: Multidrug-resistant (MDR) Acinetobacter spp. acquire antimicrobial agent- resistance genes via class 1 integrons. In this study, integrons were... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 293 |
SubjectTerms | Acinetobacter - drug effects Acinetobacter - isolation & purification Acinetobacter - metabolism Acinetobacter baumannii - drug effects Acinetobacter baumannii - isolation & purification Acinetobacter baumannii - metabolism Acinetobacter Infections - epidemiology Acinetobacter Infections - microbiology Anti-Bacterial Agents - pharmacology DNA, Bacterial - chemistry DNA, Bacterial - metabolism Drug Resistance, Multiple, Bacterial Humans Integrons - genetics Microbial Sensitivity Tests Multilocus Sequence Typing Original Polymerase Chain Reaction Republic of Korea 병리학 |
Title | Epidemiological Characterizations of Class 1 Integrons from Multidrug-Resistant Acinetobacter Isolates in Daejeon, Korea |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24982834 https://www.proquest.com/docview/1542299789 https://pubmed.ncbi.nlm.nih.gov/PMC4071186 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001886898 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Annals of Laboratory Medicine, 2014, 34(4), , pp.293-299 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELa2i4S4IN6Ux8pInBAuduw4yQGh1bLLFlQOiEq9WfEju2UrB9JWWv49M0laKKqQOEVJHDvx52S-L_bMEPLSZ0JV3FdMyswzJXjBcmVLJhTctgva8hSdkyef9flUfZylswOySW_Vd-Byr7TDfFLTZjG6_vHzHbzwb1FxSiXflAt0KRdqJNVIjcB-DcgNMEwatdikZ_vdh3nz1wVsomIy57qb59xfy46lGsSm2kdC_15L-YdxOrtDbveskh53w-AuOQjxHrk56efN75Pr09-JYBEVerKN09y7YdK6om2CTCrouA0hgQfR-YS2Prq-WV-wL2GJdDOu6DHWi98CrIOOYQAjZ6XzSN-X4Vuo42v6qQY--oBMz06_npyzPucCc0omKxbS1HELqsnmifdFWZQyAMPiZV6VGtRRsF4LXVmbySBCkhVBB186iclkZeK4fEgOYx3DY0JVmtqQAYHIZKVcmhSOB62DcD7PfcHtkPBN_xrXByTHvBgLA8IEITEAiUFIjFRGGYBkSF5tL_neReP4V-EXAJq5cnODMbRxe1Gbq8aAUhiD5Em40lBmA6mB9wonS8oY6vXSALVMwFRneTEkjzqIt02CZAWhKtWQZDvgbwtge7tn4vyyjd2N-lnk-sn_PMhTcgv3u0XCz8jhqlmH50CFVvaIDD7MxFE7zH8BpwYHow |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiological+Characterizations+of+Class+1+Integrons+from+Multidrug-Resistant+Acinetobacter+Isolates+in+Daejeon%2C+Korea&rft.jtitle=Annals+of+laboratory+medicine&rft.au=Sung%2C+Ji+Youn&rft.au=Koo%2C+Sun+Hoe&rft.au=Kim%2C+Semi&rft.au=Kwon%2C+Kye+Chul&rft.date=2014-07-01&rft.issn=2234-3806&rft.eissn=2234-3814&rft.volume=34&rft.issue=4&rft.spage=293&rft.epage=299&rft_id=info:doi/10.3343%2Falm.2014.34.4.293&rft.externalDBID=n%2Fa&rft.externalDocID=10_3343_alm_2014_34_4_293 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-3806&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-3806&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-3806&client=summon |